nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—ABCG2—Fluorouracil—head and neck cancer	0.154	0.215	CbGbCtD
Zafirlukast—CYP2D6—Hydroxyurea—head and neck cancer	0.137	0.191	CbGbCtD
Zafirlukast—ABCG2—Docetaxel—head and neck cancer	0.118	0.164	CbGbCtD
Zafirlukast—CYP2C8—Fluorouracil—head and neck cancer	0.0821	0.115	CbGbCtD
Zafirlukast—CYP1A2—Fluorouracil—head and neck cancer	0.0635	0.0887	CbGbCtD
Zafirlukast—CYP2C9—Fluorouracil—head and neck cancer	0.0572	0.0799	CbGbCtD
Zafirlukast—CYP2D6—Vinblastine—head and neck cancer	0.0485	0.0677	CbGbCtD
Zafirlukast—CYP3A4—Vinblastine—head and neck cancer	0.0308	0.043	CbGbCtD
Zafirlukast—CYP3A4—Docetaxel—head and neck cancer	0.0254	0.0355	CbGbCtD
Zafirlukast—Digestion impaired—Hydroxyurea—head and neck cancer	0.0049	0.0301	CcSEcCtD
Zafirlukast—Blister—Hydroxyurea—head and neck cancer	0.00454	0.028	CcSEcCtD
Zafirlukast—Numbness—Vinblastine—head and neck cancer	0.00433	0.0267	CcSEcCtD
Zafirlukast—Hepatotoxicity—Hydroxyurea—head and neck cancer	0.00424	0.0261	CcSEcCtD
Zafirlukast—Sensory loss—Vinblastine—head and neck cancer	0.00414	0.0255	CcSEcCtD
Zafirlukast—Rectal haemorrhage—Vinblastine—head and neck cancer	0.00397	0.0245	CcSEcCtD
Zafirlukast—Raised liver function tests—Docetaxel—head and neck cancer	0.00368	0.0227	CcSEcCtD
Zafirlukast—Blister—Fluorouracil—head and neck cancer	0.00327	0.0201	CcSEcCtD
Zafirlukast—Numbness—Fluorouracil—head and neck cancer	0.00284	0.0175	CcSEcCtD
Zafirlukast—Sensory loss—Fluorouracil—head and neck cancer	0.00272	0.0167	CcSEcCtD
Zafirlukast—Hepatic failure—Hydroxyurea—head and neck cancer	0.00264	0.0163	CcSEcCtD
Zafirlukast—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.00249	0.0153	CcSEcCtD
Zafirlukast—Throat sore—Docetaxel—head and neck cancer	0.00236	0.0145	CcSEcCtD
Zafirlukast—Oropharyngeal discomfort—Docetaxel—head and neck cancer	0.00234	0.0144	CcSEcCtD
Zafirlukast—Hepatotoxicity—Docetaxel—head and neck cancer	0.0022	0.0136	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00197	0.0121	CcSEcCtD
Zafirlukast—Swelling—Fluorouracil—head and neck cancer	0.00194	0.0119	CcSEcCtD
Zafirlukast—Neutropenia—Hydroxyurea—head and neck cancer	0.00192	0.0118	CcSEcCtD
Zafirlukast—Agranulocytosis—Vinblastine—head and neck cancer	0.00187	0.0115	CcSEcCtD
Zafirlukast—Oropharyngeal pain—Docetaxel—head and neck cancer	0.00187	0.0115	CcSEcCtD
Zafirlukast—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.00187	0.0115	CcSEcCtD
Zafirlukast—Haemoglobin—Vinblastine—head and neck cancer	0.00181	0.0112	CcSEcCtD
Zafirlukast—Haemorrhage—Vinblastine—head and neck cancer	0.0018	0.0111	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00179	0.011	CcSEcCtD
Zafirlukast—Hypoaesthesia—Vinblastine—head and neck cancer	0.00179	0.011	CcSEcCtD
Zafirlukast—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00179	0.011	CcSEcCtD
Zafirlukast—Haemoglobin—Hydroxyurea—head and neck cancer	0.00165	0.0102	CcSEcCtD
Zafirlukast—Influenza like illness—Docetaxel—head and neck cancer	0.00165	0.0102	CcSEcCtD
Zafirlukast—Haemorrhage—Hydroxyurea—head and neck cancer	0.00164	0.0101	CcSEcCtD
Zafirlukast—Neuropathy—Docetaxel—head and neck cancer	0.0016	0.00983	CcSEcCtD
Zafirlukast—Eosinophilia—Fluorouracil—head and neck cancer	0.00146	0.00901	CcSEcCtD
Zafirlukast—Ill-defined disorder—Vinblastine—head and neck cancer	0.00146	0.00896	CcSEcCtD
Zafirlukast—Malaise—Vinblastine—head and neck cancer	0.00141	0.00871	CcSEcCtD
Zafirlukast—Swelling—Docetaxel—head and neck cancer	0.0014	0.00861	CcSEcCtD
Zafirlukast—Hepatic failure—Docetaxel—head and neck cancer	0.00137	0.00846	CcSEcCtD
Zafirlukast—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00133	0.00817	CcSEcCtD
Zafirlukast—Discomfort—Vinblastine—head and neck cancer	0.00132	0.00813	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00129	0.00795	CcSEcCtD
Zafirlukast—Dermatitis bullous—Docetaxel—head and neck cancer	0.00129	0.00795	CcSEcCtD
Zafirlukast—Malaise—Hydroxyurea—head and neck cancer	0.00129	0.00794	CcSEcCtD
Zafirlukast—Thrombocytopenia—Vinblastine—head and neck cancer	0.00125	0.00772	CcSEcCtD
Zafirlukast—Sinusitis—Fluorouracil—head and neck cancer	0.00124	0.00761	CcSEcCtD
Zafirlukast—Agranulocytosis—Fluorouracil—head and neck cancer	0.00123	0.00757	CcSEcCtD
Zafirlukast—Discomfort—Hydroxyurea—head and neck cancer	0.0012	0.00741	CcSEcCtD
Zafirlukast—Haemoglobin—Fluorouracil—head and neck cancer	0.00119	0.00732	CcSEcCtD
Zafirlukast—Haemorrhage—Fluorouracil—head and neck cancer	0.00118	0.00728	CcSEcCtD
Zafirlukast—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00118	0.00725	CcSEcCtD
Zafirlukast—Oedema—Hydroxyurea—head and neck cancer	0.00117	0.00719	CcSEcCtD
Zafirlukast—Infection—Hydroxyurea—head and neck cancer	0.00116	0.00714	CcSEcCtD
Zafirlukast—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00114	0.00704	CcSEcCtD
Zafirlukast—Liver function test abnormal—Docetaxel—head and neck cancer	0.00114	0.00702	CcSEcCtD
Zafirlukast—Pain—Vinblastine—head and neck cancer	0.00109	0.00674	CcSEcCtD
Zafirlukast—Feeling abnormal—Vinblastine—head and neck cancer	0.00105	0.0065	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00105	0.00645	CcSEcCtD
Zafirlukast—Dyspepsia—Hydroxyurea—head and neck cancer	0.00103	0.00633	CcSEcCtD
Zafirlukast—Abdominal pain—Vinblastine—head and neck cancer	0.00101	0.00623	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00101	0.00621	CcSEcCtD
Zafirlukast—Fatigue—Hydroxyurea—head and neck cancer	0.00101	0.0062	CcSEcCtD
Zafirlukast—Pain—Hydroxyurea—head and neck cancer	0.000998	0.00615	CcSEcCtD
Zafirlukast—Neutropenia—Docetaxel—head and neck cancer	0.000997	0.00614	CcSEcCtD
Zafirlukast—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000962	0.00592	CcSEcCtD
Zafirlukast—Hypersensitivity—Vinblastine—head and neck cancer	0.000943	0.00581	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000932	0.00574	CcSEcCtD
Zafirlukast—Jaundice—Docetaxel—head and neck cancer	0.000927	0.00571	CcSEcCtD
Zafirlukast—Body temperature increased—Hydroxyurea—head and neck cancer	0.000923	0.00568	CcSEcCtD
Zafirlukast—Asthenia—Vinblastine—head and neck cancer	0.000918	0.00566	CcSEcCtD
Zafirlukast—Agranulocytosis—Docetaxel—head and neck cancer	0.000887	0.00547	CcSEcCtD
Zafirlukast—Myalgia—Fluorouracil—head and neck cancer	0.000877	0.0054	CcSEcCtD
Zafirlukast—Diarrhoea—Vinblastine—head and neck cancer	0.000876	0.00539	CcSEcCtD
Zafirlukast—Discomfort—Fluorouracil—head and neck cancer	0.000866	0.00533	CcSEcCtD
Zafirlukast—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00086	0.0053	CcSEcCtD
Zafirlukast—Haemoglobin—Docetaxel—head and neck cancer	0.000858	0.00528	CcSEcCtD
Zafirlukast—Hepatitis—Docetaxel—head and neck cancer	0.000854	0.00526	CcSEcCtD
Zafirlukast—Haemorrhage—Docetaxel—head and neck cancer	0.000854	0.00526	CcSEcCtD
Zafirlukast—Hypoaesthesia—Docetaxel—head and neck cancer	0.000849	0.00523	CcSEcCtD
Zafirlukast—Dizziness—Vinblastine—head and neck cancer	0.000847	0.00521	CcSEcCtD
Zafirlukast—Oedema—Fluorouracil—head and neck cancer	0.00084	0.00517	CcSEcCtD
Zafirlukast—Asthenia—Hydroxyurea—head and neck cancer	0.000838	0.00516	CcSEcCtD
Zafirlukast—Infection—Fluorouracil—head and neck cancer	0.000835	0.00514	CcSEcCtD
Zafirlukast—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000823	0.00507	CcSEcCtD
Zafirlukast—Vomiting—Vinblastine—head and neck cancer	0.000814	0.00501	CcSEcCtD
Zafirlukast—Headache—Vinblastine—head and neck cancer	0.000802	0.00494	CcSEcCtD
Zafirlukast—Diarrhoea—Hydroxyurea—head and neck cancer	0.000799	0.00492	CcSEcCtD
Zafirlukast—Dizziness—Hydroxyurea—head and neck cancer	0.000772	0.00475	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000766	0.00471	CcSEcCtD
Zafirlukast—Nausea—Vinblastine—head and neck cancer	0.00076	0.00468	CcSEcCtD
Zafirlukast—Insomnia—Fluorouracil—head and neck cancer	0.00076	0.00468	CcSEcCtD
Zafirlukast—Vomiting—Hydroxyurea—head and neck cancer	0.000742	0.00457	CcSEcCtD
Zafirlukast—Dyspepsia—Fluorouracil—head and neck cancer	0.00074	0.00456	CcSEcCtD
Zafirlukast—Rash—Hydroxyurea—head and neck cancer	0.000736	0.00453	CcSEcCtD
Zafirlukast—Dermatitis—Hydroxyurea—head and neck cancer	0.000735	0.00453	CcSEcCtD
Zafirlukast—Headache—Hydroxyurea—head and neck cancer	0.000731	0.0045	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000725	0.00447	CcSEcCtD
Zafirlukast—Back pain—Docetaxel—head and neck cancer	0.000719	0.00443	CcSEcCtD
Zafirlukast—Pain—Fluorouracil—head and neck cancer	0.000719	0.00443	CcSEcCtD
Zafirlukast—Nausea—Hydroxyurea—head and neck cancer	0.000693	0.00427	CcSEcCtD
Zafirlukast—Feeling abnormal—Fluorouracil—head and neck cancer	0.000692	0.00426	CcSEcCtD
Zafirlukast—Urticaria—Fluorouracil—head and neck cancer	0.000668	0.00411	CcSEcCtD
Zafirlukast—Body temperature increased—Fluorouracil—head and neck cancer	0.000664	0.00409	CcSEcCtD
Zafirlukast—Myalgia—Docetaxel—head and neck cancer	0.000633	0.0039	CcSEcCtD
Zafirlukast—Arthralgia—Docetaxel—head and neck cancer	0.000633	0.0039	CcSEcCtD
Zafirlukast—Hypersensitivity—Fluorouracil—head and neck cancer	0.000619	0.00381	CcSEcCtD
Zafirlukast—Oedema—Docetaxel—head and neck cancer	0.000607	0.00374	CcSEcCtD
Zafirlukast—Infection—Docetaxel—head and neck cancer	0.000603	0.00371	CcSEcCtD
Zafirlukast—Pruritus—Fluorouracil—head and neck cancer	0.000595	0.00366	CcSEcCtD
Zafirlukast—Thrombocytopenia—Docetaxel—head and neck cancer	0.000594	0.00366	CcSEcCtD
Zafirlukast—Diarrhoea—Fluorouracil—head and neck cancer	0.000575	0.00354	CcSEcCtD
Zafirlukast—Dizziness—Fluorouracil—head and neck cancer	0.000556	0.00342	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000553	0.0034	CcSEcCtD
Zafirlukast—Insomnia—Docetaxel—head and neck cancer	0.000549	0.00338	CcSEcCtD
Zafirlukast—Vomiting—Fluorouracil—head and neck cancer	0.000534	0.00329	CcSEcCtD
Zafirlukast—Dyspepsia—Docetaxel—head and neck cancer	0.000534	0.00329	CcSEcCtD
Zafirlukast—Rash—Fluorouracil—head and neck cancer	0.00053	0.00326	CcSEcCtD
Zafirlukast—Dermatitis—Fluorouracil—head and neck cancer	0.000529	0.00326	CcSEcCtD
Zafirlukast—Headache—Fluorouracil—head and neck cancer	0.000526	0.00324	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000524	0.00322	CcSEcCtD
Zafirlukast—Fatigue—Docetaxel—head and neck cancer	0.000523	0.00322	CcSEcCtD
Zafirlukast—Pain—Docetaxel—head and neck cancer	0.000519	0.00319	CcSEcCtD
Zafirlukast—Feeling abnormal—Docetaxel—head and neck cancer	0.0005	0.00308	CcSEcCtD
Zafirlukast—Nausea—Fluorouracil—head and neck cancer	0.000499	0.00307	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000496	0.00305	CcSEcCtD
Zafirlukast—Body temperature increased—Docetaxel—head and neck cancer	0.000479	0.00295	CcSEcCtD
Zafirlukast—Abdominal pain—Docetaxel—head and neck cancer	0.000479	0.00295	CcSEcCtD
Zafirlukast—Hypersensitivity—Docetaxel—head and neck cancer	0.000447	0.00275	CcSEcCtD
Zafirlukast—Asthenia—Docetaxel—head and neck cancer	0.000435	0.00268	CcSEcCtD
Zafirlukast—Pruritus—Docetaxel—head and neck cancer	0.000429	0.00264	CcSEcCtD
Zafirlukast—Diarrhoea—Docetaxel—head and neck cancer	0.000415	0.00256	CcSEcCtD
Zafirlukast—Dizziness—Docetaxel—head and neck cancer	0.000401	0.00247	CcSEcCtD
Zafirlukast—Vomiting—Docetaxel—head and neck cancer	0.000386	0.00237	CcSEcCtD
Zafirlukast—Rash—Docetaxel—head and neck cancer	0.000382	0.00235	CcSEcCtD
Zafirlukast—Dermatitis—Docetaxel—head and neck cancer	0.000382	0.00235	CcSEcCtD
Zafirlukast—Headache—Docetaxel—head and neck cancer	0.00038	0.00234	CcSEcCtD
Zafirlukast—Nausea—Docetaxel—head and neck cancer	0.00036	0.00222	CcSEcCtD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.000242	0.002	CbGpPWpGaD
Zafirlukast—ABCG2—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	0.000242	0.002	CbGpPWpGaD
Zafirlukast—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000241	0.00199	CbGpPWpGaD
Zafirlukast—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000238	0.00196	CbGpPWpGaD
Zafirlukast—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000238	0.00196	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000237	0.00195	CbGpPWpGaD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.000235	0.00194	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.000235	0.00193	CbGpPWpGaD
Zafirlukast—PTGS1—Biological oxidations—CYP1A1—head and neck cancer	0.000231	0.0019	CbGpPWpGaD
Zafirlukast—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00023	0.0019	CbGpPWpGaD
Zafirlukast—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.00023	0.00189	CbGpPWpGaD
Zafirlukast—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000228	0.00188	CbGpPWpGaD
Zafirlukast—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000221	0.00183	CbGpPWpGaD
Zafirlukast—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	0.00022	0.00182	CbGpPWpGaD
Zafirlukast—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000218	0.0018	CbGpPWpGaD
Zafirlukast—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000213	0.00175	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—UROD—head and neck cancer	0.000211	0.00174	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.00021	0.00173	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—GRP—head and neck cancer	0.000203	0.00167	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—UROD—head and neck cancer	0.000203	0.00167	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—STAT6—head and neck cancer	0.000197	0.00163	CbGpPWpGaD
Zafirlukast—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000195	0.00161	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.000194	0.0016	CbGpPWpGaD
Zafirlukast—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000194	0.0016	CbGpPWpGaD
Zafirlukast—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.000187	0.00154	CbGpPWpGaD
Zafirlukast—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000186	0.00153	CbGpPWpGaD
Zafirlukast—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000183	0.00151	CbGpPWpGaD
Zafirlukast—CYP2E1—Biological oxidations—GSTM1—head and neck cancer	0.000182	0.0015	CbGpPWpGaD
Zafirlukast—CYP2E1—Metapathway biotransformation—GSTM1—head and neck cancer	0.000179	0.00148	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000177	0.00146	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—YAP1—head and neck cancer	0.000174	0.00144	CbGpPWpGaD
Zafirlukast—CYP2E1—Biological oxidations—CYP1A1—head and neck cancer	0.000172	0.00142	CbGpPWpGaD
Zafirlukast—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000171	0.00141	CbGpPWpGaD
Zafirlukast—CYP2E1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00017	0.0014	CbGpPWpGaD
Zafirlukast—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000168	0.00139	CbGpPWpGaD
Zafirlukast—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000166	0.00137	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000164	0.00135	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000157	0.0013	CbGpPWpGaD
Zafirlukast—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	0.000157	0.0013	CbGpPWpGaD
Zafirlukast—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	0.000155	0.00128	CbGpPWpGaD
Zafirlukast—ABCG2—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	0.000154	0.00127	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—UROD—head and neck cancer	0.000152	0.00125	CbGpPWpGaD
Zafirlukast—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000151	0.00124	CbGpPWpGaD
Zafirlukast—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	0.000149	0.00123	CbGpPWpGaD
Zafirlukast—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000147	0.00121	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—IL2—head and neck cancer	0.000146	0.0012	CbGpPWpGaD
Zafirlukast—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	0.00014	0.00116	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000139	0.00115	CbGpPWpGaD
Zafirlukast—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	0.000138	0.00114	CbGpPWpGaD
Zafirlukast—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	0.000133	0.0011	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—IL2—head and neck cancer	0.000132	0.00109	CbGpPWpGaD
Zafirlukast—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000131	0.00108	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—UROD—head and neck cancer	0.000131	0.00108	CbGpPWpGaD
Zafirlukast—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	0.000129	0.00106	CbGpPWpGaD
Zafirlukast—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	0.000128	0.00106	CbGpPWpGaD
Zafirlukast—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	0.000127	0.00105	CbGpPWpGaD
Zafirlukast—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	0.000126	0.00104	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.000126	0.00104	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.000125	0.00104	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.000125	0.00104	CbGpPWpGaD
Zafirlukast—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	0.000122	0.00101	CbGpPWpGaD
Zafirlukast—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	0.000121	0.001	CbGpPWpGaD
Zafirlukast—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000121	0.000995	CbGpPWpGaD
Zafirlukast—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00012	0.000987	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—UROD—head and neck cancer	0.000117	0.000965	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—NOTCH1—head and neck cancer	0.000113	0.000936	CbGpPWpGaD
Zafirlukast—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	0.000109	0.000902	CbGpPWpGaD
Zafirlukast—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	0.000108	0.000889	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—UROD—head and neck cancer	0.000108	0.000888	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—UROD—head and neck cancer	0.000107	0.00088	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—MAPK3—head and neck cancer	0.000106	0.000876	CbGpPWpGaD
Zafirlukast—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	0.000104	0.000855	CbGpPWpGaD
Zafirlukast—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000102	0.000843	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000102	0.000839	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—MAPK1—head and neck cancer	0.000101	0.000834	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—EGFR—head and neck cancer	0.000101	0.000834	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—IL2—head and neck cancer	0.000101	0.000832	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.000101	0.000831	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—PIK3CA—head and neck cancer	9.66e-05	0.000797	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—IL2—head and neck cancer	9.16e-05	0.000755	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—UROD—head and neck cancer	9.12e-05	0.000752	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	9.08e-05	0.000749	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	8.95e-05	0.000738	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	8.86e-05	0.000731	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—PIK3CA—head and neck cancer	8.77e-05	0.000723	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—NAT2—head and neck cancer	8.77e-05	0.000723	CbGpPWpGaD
Zafirlukast—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	8.44e-05	0.000696	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—NAT2—head and neck cancer	8.43e-05	0.000695	CbGpPWpGaD
Zafirlukast—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	8.32e-05	0.000686	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	8.28e-05	0.000683	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—HRAS—head and neck cancer	8.12e-05	0.000669	CbGpPWpGaD
Zafirlukast—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	8e-05	0.00066	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—AKT1—head and neck cancer	7.89e-05	0.000651	CbGpPWpGaD
Zafirlukast—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	7.89e-05	0.000651	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—NOTCH1—head and neck cancer	7.86e-05	0.000649	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—IL2—head and neck cancer	7.81e-05	0.000644	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—DPYD—head and neck cancer	7.69e-05	0.000634	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCND1—head and neck cancer	7.61e-05	0.000628	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—DPYD—head and neck cancer	7.39e-05	0.000609	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—MAPK3—head and neck cancer	7.36e-05	0.000607	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PTEN—head and neck cancer	7.35e-05	0.000606	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—YAP1—head and neck cancer	7.3e-05	0.000602	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—AKT1—head and neck cancer	7.17e-05	0.000591	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	7.07e-05	0.000583	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—UROD—head and neck cancer	7.04e-05	0.00058	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—YAP1—head and neck cancer	7.01e-05	0.000578	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—MAPK1—head and neck cancer	7.01e-05	0.000578	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—EGFR—head and neck cancer	7.01e-05	0.000578	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—PIK3CA—head and neck cancer	6.7e-05	0.000552	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—VEGFA—head and neck cancer	6.63e-05	0.000547	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—STAT3—head and neck cancer	6.57e-05	0.000542	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—NAT2—head and neck cancer	6.3e-05	0.000519	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—MAPK3—head and neck cancer	6.28e-05	0.000518	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—PIK3CA—head and neck cancer	6.08e-05	0.000501	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—MAPK1—head and neck cancer	5.97e-05	0.000493	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—EGFR—head and neck cancer	5.97e-05	0.000492	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.78e-05	0.000477	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	5.72e-05	0.000472	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—HRAS—head and neck cancer	5.63e-05	0.000464	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—DPYD—head and neck cancer	5.52e-05	0.000455	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—AKT1—head and neck cancer	5.47e-05	0.000451	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—NAT2—head and neck cancer	5.44e-05	0.000449	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IL2—head and neck cancer	5.41e-05	0.000446	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCND1—head and neck cancer	5.27e-05	0.000435	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.27e-05	0.000435	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—YAP1—head and neck cancer	5.24e-05	0.000432	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PIK3CA—head and neck cancer	5.18e-05	0.000427	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.16e-05	0.000426	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	5.11e-05	0.000421	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PTEN—head and neck cancer	5.09e-05	0.00042	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TP53—head and neck cancer	5.01e-05	0.000413	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—AKT1—head and neck cancer	4.97e-05	0.00041	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—NAT2—head and neck cancer	4.86e-05	0.000401	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—HRAS—head and neck cancer	4.79e-05	0.000395	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—DPYD—head and neck cancer	4.77e-05	0.000394	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.7e-05	0.000388	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.66e-05	0.000384	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—VEGFA—head and neck cancer	4.6e-05	0.000379	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.59e-05	0.000379	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—STAT3—head and neck cancer	4.55e-05	0.000376	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—YAP1—head and neck cancer	4.53e-05	0.000374	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—NAT2—head and neck cancer	4.47e-05	0.000369	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—NAT2—head and neck cancer	4.43e-05	0.000365	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—TYMS—head and neck cancer	4.38e-05	0.000361	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MAPK3—head and neck cancer	4.35e-05	0.000359	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—GSTM1—head and neck cancer	4.33e-05	0.000357	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—DPYD—head and neck cancer	4.26e-05	0.000351	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—AKT1—head and neck cancer	4.23e-05	0.000349	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—TYMS—head and neck cancer	4.21e-05	0.000347	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—GSTM1—head and neck cancer	4.16e-05	0.000343	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—GPX1—head and neck cancer	4.15e-05	0.000342	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MAPK1—head and neck cancer	4.14e-05	0.000341	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—EGFR—head and neck cancer	4.14e-05	0.000341	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CYP1A1—head and neck cancer	4.11e-05	0.000339	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—YAP1—head and neck cancer	4.04e-05	0.000333	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.02e-05	0.000332	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—GPX1—head and neck cancer	3.99e-05	0.000329	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.98e-05	0.000328	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CYP1A1—head and neck cancer	3.95e-05	0.000325	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—DPYD—head and neck cancer	3.92e-05	0.000323	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—DPYD—head and neck cancer	3.88e-05	0.00032	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—NAT2—head and neck cancer	3.79e-05	0.000312	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—YAP1—head and neck cancer	3.72e-05	0.000307	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—YAP1—head and neck cancer	3.69e-05	0.000304	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PIK3CA—head and neck cancer	3.59e-05	0.000296	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TP53—head and neck cancer	3.47e-05	0.000287	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.4e-05	0.000281	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HRAS—head and neck cancer	3.32e-05	0.000274	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—DPYD—head and neck cancer	3.32e-05	0.000274	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.24e-05	0.000267	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—YAP1—head and neck cancer	3.15e-05	0.00026	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—TYMS—head and neck cancer	3.15e-05	0.00026	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GSTM1—head and neck cancer	3.11e-05	0.000257	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.04e-05	0.000251	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GPX1—head and neck cancer	2.98e-05	0.000246	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.97e-05	0.000245	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CYP1A1—head and neck cancer	2.95e-05	0.000243	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—AKT1—head and neck cancer	2.93e-05	0.000242	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NAT2—head and neck cancer	2.92e-05	0.000241	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.77e-05	0.000228	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—TYMS—head and neck cancer	2.72e-05	0.000224	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GSTM1—head and neck cancer	2.69e-05	0.000222	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.65e-05	0.000218	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GPX1—head and neck cancer	2.57e-05	0.000212	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—DPYD—head and neck cancer	2.56e-05	0.000211	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CYP1A1—head and neck cancer	2.55e-05	0.00021	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PTGS2—head and neck cancer	2.44e-05	0.000201	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—YAP1—head and neck cancer	2.43e-05	0.000201	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—TYMS—head and neck cancer	2.43e-05	0.0002	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.42e-05	0.000199	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GSTM1—head and neck cancer	2.4e-05	0.000198	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.37e-05	0.000195	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PTGS2—head and neck cancer	2.35e-05	0.000194	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GPX1—head and neck cancer	2.3e-05	0.00019	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYP1A1—head and neck cancer	2.27e-05	0.000188	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—TYMS—head and neck cancer	2.23e-05	0.000184	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—TYMS—head and neck cancer	2.21e-05	0.000183	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GSTM1—head and neck cancer	2.21e-05	0.000182	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GSTM1—head and neck cancer	2.19e-05	0.00018	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PTEN—head and neck cancer	2.13e-05	0.000176	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GPX1—head and neck cancer	2.11e-05	0.000174	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GPX1—head and neck cancer	2.1e-05	0.000173	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.09e-05	0.000173	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP1A1—head and neck cancer	2.09e-05	0.000173	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP1A1—head and neck cancer	2.07e-05	0.000171	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.06e-05	0.00017	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PTEN—head and neck cancer	2.05e-05	0.000169	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—TYMS—head and neck cancer	1.89e-05	0.000156	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GSTM1—head and neck cancer	1.87e-05	0.000154	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.87e-05	0.000154	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GPX1—head and neck cancer	1.79e-05	0.000148	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP1A1—head and neck cancer	1.77e-05	0.000146	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTGS2—head and neck cancer	1.75e-05	0.000145	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.7e-05	0.000141	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTEN—head and neck cancer	1.53e-05	0.000126	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTGS2—head and neck cancer	1.52e-05	0.000125	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CA—head and neck cancer	1.5e-05	0.000124	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—TYMS—head and neck cancer	1.46e-05	0.00012	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.46e-05	0.00012	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CA—head and neck cancer	1.44e-05	0.000119	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.44e-05	0.000119	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GPX1—head and neck cancer	1.38e-05	0.000114	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.37e-05	0.000113	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTGS2—head and neck cancer	1.35e-05	0.000112	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTEN—head and neck cancer	1.32e-05	0.000109	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTGS2—head and neck cancer	1.24e-05	0.000103	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTGS2—head and neck cancer	1.23e-05	0.000102	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—AKT1—head and neck cancer	1.23e-05	0.000101	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTEN—head and neck cancer	1.18e-05	9.73e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—AKT1—head and neck cancer	1.18e-05	9.73e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTEN—head and neck cancer	1.09e-05	8.95e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CA—head and neck cancer	1.08e-05	8.9e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTEN—head and neck cancer	1.08e-05	8.87e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTGS2—head and neck cancer	1.05e-05	8.69e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CA—head and neck cancer	9.32e-06	7.69e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTEN—head and neck cancer	9.19e-06	7.58e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—AKT1—head and neck cancer	8.81e-06	7.27e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CA—head and neck cancer	8.32e-06	6.86e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTGS2—head and neck cancer	8.14e-06	6.71e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CA—head and neck cancer	7.66e-06	6.31e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—AKT1—head and neck cancer	7.62e-06	6.28e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CA—head and neck cancer	7.59e-06	6.26e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTEN—head and neck cancer	7.09e-06	5.85e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—AKT1—head and neck cancer	6.8e-06	5.61e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CA—head and neck cancer	6.49e-06	5.35e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—AKT1—head and neck cancer	6.25e-06	5.16e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—AKT1—head and neck cancer	6.2e-06	5.11e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—AKT1—head and neck cancer	5.3e-06	4.37e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CA—head and neck cancer	5.01e-06	4.13e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—AKT1—head and neck cancer	4.09e-06	3.37e-05	CbGpPWpGaD
